Infinity to Present at Deutsche Bank Securities' 2012 dbAccess Biofest

Before you go, we thought you'd like these...
Before you go close icon

Infinity to Present at Deutsche Bank Securities' 2012 dbAccess Biofest

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Infinity Pharmaceuticals, Inc. (NAS: INFI) will be presenting at the 2012 dbAccess Biofest on December 3, 2012 at 1:40 p.m. ET in Boston.

A live webcast of this Infinity presentation will be accessible on the Investors/Media section of Infinity's website at www.infi.com, and will be available for 30 days following the event.


About Infinity Pharmaceuticals, Inc.

Infinity is an innovative drug discovery and development company seeking to discover, develop and deliver to patients best-in-class medicines for diseases with significant unmet need. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity's programs focused on the inhibition of phosphoinositide-3-kinase and heat shock protein 90 are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company's website at www.infi.com.



Infinity Pharmaceuticals, Inc.
Kate Murray, 617-453-1179
Kate.Murray@infi.com
http://www.infi.com

KEYWORDS:   United States  North America  Massachusetts

INDUSTRY KEYWORDS:

The article Infinity to Present at Deutsche Bank Securities' 2012 dbAccess Biofest originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners